Proqr Therapeutics Nv

Penny Stocks Biotech Stocks Healthcare Stocks

$1.86

+0.03 (+1.64%)

As of Jun 30, 10:28 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +394.6% upside

Low Target $6.27

Average Target $9.20

High Target $10.38

Current Price $1.86

Current
$1.86

Target
$9.20

$6.27 $9.20 avg $10.38

Scenario Analysis

Bear Case

$6.27

237.1%

Low target

Base Case

$9.20

+394.6%

Avg target

Bull Case

$10.38

+458.1%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.10

-40.0% from high

52-Week Low

$1.33

+39.8% from low

Target vs 52W High

$9.20

+196.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%